A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this study is to measure the feasibility of delivering a co-designed exercise programme for patients with cancer receiving chemotherapy treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PEACH Trial: Prescribed Exercise After Chemotherapy

NCT01030887

Cancer

COMPLETED PHASE3

Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients

NCT07182773

Cancer

NOT_YET_RECRUITING NA

The Feasibility of Implementing an Exercise Programme for Deconditioned Cancer Survivors

NCT04026659

Cancer

COMPLETED NA

Exercise as an Intervention in Endometrial Cancer Survivors

NCT02367950

Endometrial Cancer Quality of Life

UNKNOWN NA

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

NCT01789983

Breast Cancer Colon Cancer Lung Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Exercise has been shown to play an important role in reducing many of the side effects associated with chemotherapy treatment. Exercise can help to improve symptoms of fatigue, nausea, muscle weakness, and pain, which in turn can help to improve patients overall quality of life and wellbeing. In addition to this, exercising during chemotherapy can also help to maintain physical fitness and preserve muscle mass, which has been shown to significantly reduce treatment toxicities. Despite these benefits of exercise, performing regular physical activity during chemotherapy poses significant challenges. Patients are faced with a number of physical and logistical barriers during chemotherapy which makes it difficult to engage in regular exercise. In addition to this, exercise programs that are being designed lack flexibility and individualization, and don't account for the unpredictable nature of chemotherapy treatment. It is, therefore, no surprise that patients struggle to meet the exercise recommendations during chemotherapy, and highlights the need for careful consideration when prescribing exercise during this time. In preparation for this study, the research team held a number of workshops which included a mixture of patients and healthcare professionals with the aim of co-designing an exercise intervention for patients during chemotherapy. Including public and patient involvement (PPI) in the design process will help to ensure that the exercise program that is developed is pragmatic and, most importantly, patient-centred.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Feasibility randomised controlled trial using a 2:1 randomisation

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Not indicated for this feasibility study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FIERCE Programme

The FIERCE programme will consist of an aerobic and resistance exercise program delivered for the duration of chemotherapy.

Exercise will be prescribed with the aim of achieving an overall exercise volume over the course of a chemotherapy cycle. The total volume of exercise prescribed in each cycle will be targeted towards achieving the exercise guidelines for cancer survivors which recommends 90 minutes of aerobic activity per week, in addition to resistance exercise at least two times per week.

Exercise intensity will be autoregulated by participants based on how they are feeling on a given day. Participants will be given a choice of exercising at low, moderate, or higher intensity based on how BORG rating of perceived exertion (RPE) scale.

Weekly check ins will be made to each participant over the phone by an exercise physiologist for goal setting. Participants will also be given a pedometer to monitor daily physical activity levels.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

Participants will be randomised to either the FIERCE exercise programme involving supervised exercise prescription

Health Behaviour Change (Pedometer)

Intervention Type BEHAVIORAL

Participants in both arms will be provided with a pedometer as a health behaviour change intervention

Pedometer programme

Participants randomized to the pedometer programme will receive individualised advice about exercising during chemotherapy and will also receive a pedometer to encourage daily activity. Participant in both groups will receive a personal exercise consultation to identify their individual needs and understand their exercise preferences.

Group Type ACTIVE_COMPARATOR

Health Behaviour Change (Pedometer)

Intervention Type BEHAVIORAL

Participants in both arms will be provided with a pedometer as a health behaviour change intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Participants will be randomised to either the FIERCE exercise programme involving supervised exercise prescription

Intervention Type BEHAVIORAL

Health Behaviour Change (Pedometer)

Participants in both arms will be provided with a pedometer as a health behaviour change intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \>18.
* Histological confirmed diagnosis of stage I to IIIc breast, ovarian or colorectal cancer.
* Scheduled to receive chemotherapy ± immunotherapy with curative intent.
* Medical clearance from oncologist to partake in regular exercise in accordance with American College of Sports Medicine (ACSM) preparticipation screening algorithm.
* Ability to provide written informed consent.

Exclusion Criteria

* Advanced/metastatic disease.
* Scheduled to receive concurrent chemoradiotherapy.
* Scheduled to receive high-dose chemotherapy during hospital admission.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No